Specific agents

Beta blockers
Beta blockers have become the mainstay of glaucoma medical therapy. Receptor selectivity is important, with non-selective beta blockers affecting both beta-I and beta-2 receptors, in contrast to beta-I-selective agents which are more selective for the beta-1 receptors. This selectivity affects both safety and efficacy.
Mechanism: Beta blockers reduce lOP by decreasing aqueous humour production by the ciliary body.8
Efficacy: Mean peak lOP is lowered by 25% and mean trough by 20% using non-selective agents.9.l D lOP lowering is less with betaxolol, the beta-I-selective agent.ll If beta blockers alone do not achieve adequate pressure lowering, then one of the other classes of agents can be used as adjunctive therapy. Beta blockers are generally administered twice daily. Levobunolol may be used once daily in some patients. Timolol XE is a once daily formulation. If more than one concentration of the drug is available, the lower concentration should be used and is generally as effective in the majority of patients.
Side effects: Contraindications to beta blockers include severe chronic obstructive airways disease, asthma, heart block, bradycardia and congestive cardiac failure. Other systemic side effects are also common, including neurological symptoms such as depression and malaise.
The elderly are more at risk of side effects. While selective beta blockers may lessen the incidence and severity of adverse events, they are not completely safe, Side effects: The only frequently reported systemic effect is a bitter taste after drop instillation, and the drug appears to be well tolerated, with only 5% discontinuing the drug due to an adverse event in controlled clinical trials. The majority of these side effects were ocular, and included topical discomfort and allergy.1 5 Most patients tolerate the drug well.
Prostaglandin analogues
Prostaglandins are derived from arachidonic acid and display a wide range of biological functions. 
Alpha agonists
Apraclonidine, a derivative of clonidine, was initially introduced, but is not recommended for chronic use. Side effects: Brimonidine has no effect on pulmonary function, heart rate or blood pressure?8 Possible adverse events include dry mouth and fatigue or drowsiness.
Local effects include allergy (in 12% at 12 months) and discomfort.
Cholinergic agents
Although the use of cholinergics, such as pilocarpine, has declined since the introduction of the newer drugs Future glaucoma therapy may indeed focus not only on lOP reduction but also on improved optic nerve head blood flow, neuroprotection, genetic therapy and optic nerve regeneration. However, before abandoning the concept of lOP reduction, the potential benefits of direct treatment of the optic nerve in glaucoma still need to be proven, as well as methods developed to deliver these medicines in a safe and effective manner to the target tissue.
